News & Articles

Pre-coated plates and an easy-to-use self-coating liquid allow flexible experimental designs with maximum convenience

The new instrument enables users to image an entire mouse or multiple samples at subcellular resolution in 3D

More powerful nanoparticle analysis with Raman spectroscopy, hyperspectral imaging and enhanced darkfield illumination on the same microscope platform

llumina's COVIDSeq aims to generate information about the genomic sequence of the virus

Large-scale manufacturing of rapid diagnostic test kit and reagents to enable increased testing capacity for COVID-19 worldwide

R&D expert Dr. Francisco Ylera shares the secret to fast and flexible formatting of antibodies to accelerate your research

Watch this on-demand webinar to discover how mass cytometry can be used to monitor immune responses to new therapeutics

Learn about the technical aspects and challenges to using RNAscope technology for RNA expression analysis on rodent and human dorsal root ganglion (DRG)

Join us on Thursday, June 25, to learn more about the critical factors influencing microbiome RNA sample prep and rRNA depletion strategies

Join us on Wednesday, June 24, to learn about the benefits of IM-MS for two different application areas

This aims to assist labs involved with the essential RT-PCR assay part of the “test, trace and isolate” strategy

Discover on demand an antibody discovery campaign targeting a cell surface receptor implicated in cancer

Watch this webinar to find out how directly coupling CIEF with mass spectrometry can benefit biopharmaceutical applications

Join us on Friday, June 19, to find out how massively parallel microbial strain engineering may lead to the development of novel therapeutics to combat the most difficult antibiotic-resistant pathogens

Join us on Wednesday, June 17, to find out how to optimize sample preparation for a range of complex microbiome samples

The new Fluorolog covers a broad range of luminescence research

Don't miss this webinar to find out how researchers at LifeArc are using ALK-specific antibodies as a mechanism of directly targeting ALK-expressing neuroblastoma cells

Our expert webinar series aims to help you get the most from your drug discovery research